E34.0
Carcinoid syndrome
Clinical Classification Guidelines
Code Also
- the underlying disorder, such as:
- primary neuroendocrine tumors (C7A.-)
- secondary neuroendocrine tumors (C7B.-)
Medical Intelligence & Overview
Carcinoid syndrome is a group of symptoms that occur in some people with carcinoid tumors, a type of slow-growing cancer that originates in neuroendocrine cells. These cells release hormones like serotonin, which can lead to a range of symptoms when they enter the bloodstream in significant amounts. Recognizing and understanding this syndrome is important for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Presence of carcinoid tumors, often found in the gastrointestinal tract or lungs Overproduction and release of hormones such as serotonin, tachykinins, or histamine by the tumor Metastasis of the tumor to other parts of the body, especially the liver, which often allows hormones to bypass breakdown and cause symptoms
Key Symptoms: Flushing of the skin, particularly the face and neck Watery diarrhea and abdominal pain Wheezing or asthma-like symptoms Heart valve lesions, especially affecting the right side of the heart Sudden onset of skin redness and warmth Low blood pressure during episodes Unexplained fatigue and weakness Weight loss and decreased appetite in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of carcinoid syndrome typically involves a combination of tests to measure hormone levels and imaging studies. Common approaches include:
Treatment Protocols: Managing carcinoid syndrome focuses on controlling symptoms and addressing the underlying tumor. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is E34.0 a billable ICD-10 code?
Yes, E34.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E34.0?
Clinical documentation must specify the nature of Carcinoid syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference